Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TAK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TAK · as of Jun 8, 2026
Key Statistics
Explore Takeda Pharmaceutical Company Limited Data
tak stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
Competitors & Peers
tak competitorsTAK
A
ALC
BDX
CAH
EWStock Performance
Full HistoryAbout Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin Amer…
what is takeda pharmaceutical company limited · tak stock overview · takeda pharmaceutical company limited company profile · who is takeda pharmaceutical company limited ceo · tak NYSE · takeda pharmaceutical company limited headquarters · takeda pharmaceutical company limited business segments
About Stock Overview & Key Data
Takeda Pharmaceutical Company Limited (TAK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Jan 5, 2010. As of the latest trading session, TAK stock price is $15.60, with a market capitalization of $49.3B. The stock has returned +3.65% over the past 12 months and +0.06% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Takeda Pharmaceutical Company Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2026, Takeda Pharmaceutical Company Limited reported revenue of $4.78T and net income of $203.3B. For detailed data — including Takeda Pharmaceutical Company Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Takeda Pharmaceutical Company Limited (TAK) stock price is $15.60. The stock is traded on NYSE under the ticker symbol TAK. The 52-week range is $12.99 – $18.90.